Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group
5 While its primary endpoint (a composite including all-cause mortality, nonfatal MI, stroke, acute coronary syndrome, leg revascularization, and major leg amputation) did not reach significance, a main secondary composite endpoint (all-cause mortality, nonfatal MI, and stroke) showed a significant benefit with pioglitazone (hazard ratio [HR] 0.84
The MHRA has approved these agents for specific indications, and NICE provides guidance on their use within the NHS, typically recommending them when other treatments have proven insufficient or when specific clinical criteria are met
The enzyme glutamine synthetase binds ammonia to glutamate to form L-Glutamine, effectively trapping the toxic nitrogen
What if
The dose in milligrams never changes with vial size a 2.5 mg dose is 2.5 mg whether it comes from a 5 mg or a 30 mg vial but the number of units you draw changes dramatically, because a more concentrated solution packs the same milligrams into far less liquid